Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion

Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co  is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...